CTT Pharmaceutical Holdings Inc (OTCMKTS:CTTH) Stock Soars After Updates On Worldwide Patent Portfolio

The receipt of a patent approval is almost always seen as a positive for any innovative company and hence, it could be a good time for investors to take a look into the developments at CTT Pharmaceutical Holdings Inc (OTCMKTS:CTTH).

Trading Data

On Monday, CTTH stock moved up 31.60% to $0.0329 with 97.60K shares, compared to volume of 33.69K shares. The stock moved within a range of $0.0288 – 0.0330 after opening trade at $0.0302.

CTT Pharma Updates On Worldwide Patent Portfolio

The company was in the news yesterday after it announced that it had been awarded a patent approval for its dissolvable strip technology by the relevant authorities in Israel. The latest approval takes the number of patents granted to CTT Pharmaceutical to as many as 48. That includes three patents in the United States and three each in Israel, Mexico, Europe, Australia, Canada and South Africa.

The patents that the company was awarded in Europe covers as many as 38 nations and that includes important markets like Germany, France, Italy, Switzerland and the United Kingdom among others. However, at the same time, it is also necessary to note that at this point in time the company has a total of 9 pending patents. Out of those four patents are pending in the United States, while three patents are pending in Chile, Canada and Brazil. It could well be a good time for investors to take a greater interest in CTT Pharmaceutical.